
@article{ ISI:000531099900023,
Author = {Pepin, Jean Louis and Angel Martinez-Garcia, Miguel},
Title = {{Sleep disorders and cerebrovascular disease: the long and winding road}},
Journal = {{EUROPEAN RESPIRATORY JOURNAL}},
Year = {{2020}},
Volume = {{55}},
Number = {{4}},
Month = {{APR 1}},
Publisher = {{EUROPEAN RESPIRATORY SOC JOURNALS LTD}},
Address = {{442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND}},
Type = {{Editorial Material}},
Language = {{English}},
Affiliation = {{Pepin, JL (Reprint Author), CHU Grenoble Alpes, Lab EFCR, CS10217, F-38043 Grenoble 9, France.
   Pepin, Jean Louis, Univ Grenoble Alpes, INSERM, CHU Grenoble Alpes, Grenoble, France.
   Angel Martinez-Garcia, Miguel, Polytech \& Univ La Fe Hosp, Pneumol Dept, Valencia, Spain.}},
DOI = {{10.1183/13993003.01977-2019}},
Article-Number = {{1901977}},
ISSN = {{0903-1936}},
EISSN = {{1399-3003}},
Keywords-Plus = {{STROKE; APNEA; MECHANISMS}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{JPepin@chu-grenoble.fr}},
Cited-References = {{Bassetti M, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105921.
   Benjafield AV, 2019, LANCET RESP MED, V7, P687, DOI 10.1016/S2213-2600(19)30198-5.
   Brill AK, 2018, NEUROLOGY, V90, pE1222, DOI 10.1212/WNL.0000000000005262.
   Collop NA, 2008, CRIT CARE CLIN, V24, P449, DOI 10.1016/j.ccc.2008.02.002.
   Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492.
   Javaheri S, 2019, CHEST, V156, P431, DOI 10.1016/j.chest.2019.04.092.
   Javaheri S, 2017, J AM COLL CARDIOL, V69, P841, DOI 10.1016/j.jacc.2016.11.069.
   Johnson KG, 2010, J CLIN SLEEP MED, V6, P131.
   Li M, 2014, INT J CARDIOL, V172, P466, DOI 10.1016/j.ijcard.2013.12.230.
   Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002.
   Xiao ZJ, 2018, J NEUROL, V265, P1288, DOI 10.1007/s00415-018-8810-2.
   Zinchuk AV, 2018, THORAX, V73, P472, DOI 10.1136/thoraxjnl-2017-210431.}},
Number-of-Cited-References = {{12}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Eur. Resp. J.}},
Doc-Delivery-Number = {{LK8HC}},
Unique-ID = {{ISI:000531099900023}},
OA = {{Bronze}},
DA = {{2020-05-19}},
}

@article{ ISI:000523616200030,
Author = {Soumagne, Thibaud and Roche, Nicolas and Guillien, Alicia and Bouhaddi,
   Malika and Rocchi, Steffi and Hue, Sophie and Claude, Frederic and
   Bizard, Lucie and Andujar, Pascal and Dalphin, Jean-Charles and Degano,
   Bruno},
Title = {{Cardiovascular Risk in COPD Deciphering the Contribution of Tobacco
   Smoking}},
Journal = {{CHEST}},
Year = {{2020}},
Volume = {{157}},
Number = {{4}},
Pages = {{834-845}},
Month = {{APR}},
Abstract = {{BACKGROUND: The observation that COPD is an independent risk factor for
   cardiovascular disease (CVDs) comes from comparisons between smokers
   with COPD and smokers without COPD. The mechanisms that explain
   increased risk of CVD in patients with COPD are still unclear.
   OBJECTIVES: The goal of this study was to assess systemic arterial
   stiffness (a predictor of CVD mortality) and to evaluate its
   determinants in a group of patients with mild to moderate COPD secondary
   to organic dust exposure, tobacco smoking, or both.
   METHODS: Systemic arterial stiffness was assessed by using aortic pulse
   wave velocity (aPWV). Measurements were made in 142 patients with COPD
   and 155 healthy control subjects matched for age, sex, BMI, and tobacco
   smoking, exposed to tobacco smoking (n = 56/70 for COPD/control
   subjects, respectively), organic dusts (n = 44/48), or both (n = 42/37).
   RESULTS: aPWV was higher in COPD than in healthy controls in subjects
   exposed to tobacco smoking and to both organic dusts and tobacco
   smoking. By contrast, among never smokers exposed to organic dusts,
   patients with COPD and matched control subjects had similar aPWV.
   Multivariate analysis of the 142 patients with COPD (exposed to tobacco
   smoking and/or to organic dusts) showed that tobacco smoking was
   associated with high aPWV. Moreover, soluble suppression of
   tumorigenicity 2, a marker of major cardiovascular events, was
   correlated with aPWV in these patients.
   CONCLUSIONS: Analysis of an unselected group of patients with COPD with
   different causes suggests that: (1) COPD by itself is not sufficient to
   explain increased aPWV; and (2) tobacco smoking is a risk factor for
   elevated aPWV in COPD.}},
Publisher = {{ELSEVIER}},
Address = {{RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Soumagne, T (Reprint Author), CHU Besancon, Explorat Fonct Physiol, 3 Blvd Fleming, F-25030 Besancon, France.
   Soumagne, Thibaud; Bouhaddi, Malika, CHU Besancon, Serv Physiol Explorat Fonct, Besancon, France.
   Soumagne, Thibaud; Claude, Frederic; Dalphin, Jean-Charles, CHU Besancon, Serv Pneumol, Besancon, France.
   Roche, Nicolas, Grp Hosp Cochin, AP HP, Serv Pneumol \& Soins Intensifs Resp, Site Val de Grace, Paris, France.
   Roche, Nicolas, Univ Paris 05, Sorbonne Paris Cite, EA2511, Paris, France.
   Guillien, Alicia, CNRS, EA2511, Inst Adv Biosci, UMR 5309,Ctr Rech UGA,INSERM U1209,Equipe Epidemi, Grenoble, France.
   Rocchi, Steffi, CHU Besancon, Serv Parasitol Mycol, Besancon, France.
   Hue, Sophie, Hop Henri Mondor, AP HP, Immunol Biol, Paris, France.
   Hue, Sophie; Bizard, Lucie; Andujar, Pascal, INSERM Unite U955, Equipe 4, Creteil, France.
   Andujar, Pascal, Univ Paris Est Creteil, Fac Med, Creteil, France.
   Andujar, Pascal, Ctr Hosp Intercommunal Creteil, Serv Pathol Profess \& Environm, Creteil, France.
   Dalphin, Jean-Charles, Univ Franche Comte, UMR CNRS Chrono Environm, Besancon, France.
   Degano, Bruno, CHU Grenoble Alpes, Pole Thorax \& Vaisseaux, Serv Hosp Univ Pneumol Physiol, Grenoble, France.
   Degano, Bruno, Univ Grenoble Alpes, Grenoble, France.}},
DOI = {{10.1016/j.chest.2019.11.002}},
ISSN = {{0012-3692}},
EISSN = {{1931-3543}},
Keywords = {{cardiovascular diseases; COPD; vascular stiffness}},
Keywords-Plus = {{OBSTRUCTIVE PULMONARY-DISEASE; ARTERIAL STIFFNESS; LUNG-FUNCTION;
   VASCULAR DYSFUNCTION; DUST EXPOSURE; FARMERS; INFLAMMATION; MORTALITY;
   SEVERITY; HYPOXIA}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{thibaud\_soumagne@live.fr}},
Funding-Acknowledgement = {{Novartis Pharma, France; association Le Nouveau Souffle}},
Funding-Text = {{The COPD screening program (BALISTIC) was supported by a grant from
   Novartis Pharma, France. The laboratory analyses were supported by a
   grant from the association Le Nouveau Souffle.}},
Cited-References = {{Aguilaniu B, 2011, RESP PHYSIOL NEUROBI, V177, P30, DOI 10.1016/j.resp.2011.03.005.
   Bolund ACS, 2017, OCCUP ENVIRON MED, V74, P531, DOI 10.1136/oemed-2016-103963.
   Chen WJ, 2015, LANCET RESP MED, V3, P631, DOI 10.1016/S2213-2600(15)00241-6.
   Cinarka H, 2014, RESP CARE, V59, P274, DOI 10.4187/respcare.02621.
   Decramer M, 2013, LANCET RESP MED, V1, P73, DOI 10.1016/S2213-2600(12)70060-7.
   Degano B, 2012, REV MAL RESPIR, V29, P1149, DOI 10.1016/j.rmr.2012.08.007.
   Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC.
   Eduard W, 2009, CHEST, V136, P716, DOI 10.1378/chest.08-2192.
   Gole Y, 2011, EUR J APPL PHYSIOL, V111, P937, DOI 10.1007/s00421-010-1711-4.
   Golpe R, 2018, LUNG, V196, P195, DOI 10.1007/s00408-018-0095-9.
   Guillien A, 2016, EUR RESPIR J, V47, P95, DOI 10.1183/13993003.00153-2015.
   HELIN P, 1975, ATHEROSCLEROSIS, V21, P325, DOI 10.1016/0021-9150(75)90046-5.
   Laurent S, 2012, ANN MED, V44, pS93, DOI 10.3109/07853890.2011.653398.
   Maclay JD, 2013, CHEST, V143, P798, DOI 10.1378/chest.12-0938.
   Maclay JD, 2012, THORAX, V67, P606, DOI 10.1136/thoraxjnl-2011-200949.
   Maclay JD, 2009, AM J RESP CRIT CARE, V180, P513, DOI 10.1164/rccm.200903-0414OC.
   Macnee William, 2008, Proc Am Thorac Soc, V5, P824, DOI 10.1513/pats.200807-071TH.
   Mahmud A, 2003, HYPERTENSION, V41, P183, DOI 10.1161/01.HYP.0000047464.66901.60.
   Mancia G, 1997, AM J PHYSIOL-HEART C, V273, pH1555.
   Matheson MC, 2005, THORAX, V60, P645, DOI 10.1136/thx.2004.035170.
   McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC.
   Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312.
   Sabit R, 2007, AM J RESP CRIT CARE, V175, P1259, DOI 10.1164/rccm.200701-067OC.
   Sabit R, 2010, CHEST, V138, P47, DOI 10.1378/chest.09-2764.
   Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9.
   Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805.
   Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC.
   Tan WC, 2015, THORAX, V70, P822, DOI 10.1136/thoraxjnl-2015-206938.
   van Gestel AJR, 2012, DISCOV MED, V14, P359.
   Vanfleteren LE, 2014, EUR RESPIR J, V43, P54.
   Vivodtzev I, 2014, CHEST, V145, P861, DOI 10.1378/chest.13-1809.
   Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP.
   Wagner PD, 2015, EUR RESPIR J, V45, P227, DOI 10.1183/09031936.00039214.
   Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437.
   Weinmann S, 2008, J OCCUP ENVIRON MED, V50, P561, DOI 10.1097/JOM.0b013e3181651556.
   Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173.
   Zelt JT, 2018, RESP MED, V136, P29, DOI 10.1016/j.rmed.2018.01.007.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Chest}},
Doc-Delivery-Number = {{KZ9ZB}},
Unique-ID = {{ISI:000523616200030}},
DA = {{2020-05-19}},
}

@article{ ISI:000523616200003,
Author = {Tissot, Noemie and Montani, David and Seronde, Marie-France and Degano,
   Bruno and Soumagne, Thibaud},
Title = {{Venoocclusive Disease With Both Hepatic and Pulmonary Involvement}},
Journal = {{CHEST}},
Year = {{2020}},
Volume = {{157}},
Number = {{4}},
Pages = {{E107-E109}},
Month = {{APR}},
Abstract = {{Pulmonary venoocclusive disease (PVOD) is a rare form of pulmonary
   vascular disease with pulmonary hypertension characterized by
   preferential involvement of the pulmonary venous system. Hepatic
   venoocclusive disease (HVOD), also known as sinusoidal obstruction
   syndrome, is a condition that occurs in 13\% to 15\% of patients after
   hematopoietic stem cell transplantation (HSCT). Although hepatic and
   pulmonary venoocclusive diseases may share some pathologic features as
   well as some etiologies such as HSCT, these two disorders have never
   been described together in a single adult patient. We report the case of
   a patient who received HSCT and developed HVOD and PVOD within 9 months.
   Despite their differences, PVOD and HVOD share common risk factors and
   associated conditions, suggesting that in the context of HSCT, the two
   diseases share common pathophysiological mechanisms. Optimal treatment
   for HSCT-related PVOD remains to be determined.}},
Publisher = {{ELSEVIER}},
Address = {{RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS}},
Type = {{Editorial Material}},
Language = {{English}},
Affiliation = {{Soumagne, T (Reprint Author), CHU Besancon, Serv Pneumol Oncol Thorac \& Allergol Resp, Blvd Fleming, F-25000 Besancon, France.
   Tissot, Noemie; Soumagne, Thibaud, CHU Besancon, Serv Pneumol Oncol Thorac \& Allergol Resp, Blvd Fleming, F-25000 Besancon, France.
   Montani, David, Univ Paris Saclay, Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France.
   Montani, David, Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France.
   Montani, David, Hop Marie Lannelongue, INSERM, UMR S 999, Le Plessis Robinson, France.
   Seronde, Marie-France, CHU Besancon, Serv Cardiol, Besancon, France.
   Degano, Bruno, CHU Grenoble Alpes, Pole Thorax \& Vaisseaux, Serv Hosp Univ Pneumol Physiol, La Tronche, France.
   Degano, Bruno, Univ Grenoble Alpes, Grenoble, France.}},
DOI = {{10.1016/j.chest.2019.11.021}},
ISSN = {{0012-3692}},
EISSN = {{1931-3543}},
Keywords-Plus = {{STEM-CELL TRANSPLANTATION}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{thibaud\_soumagne@live.fr}},
Cited-References = {{Bunte MC, 2008, BONE MARROW TRANSPL, V41, P677, DOI 10.1038/sj.bmt.1705990.
   Coppell JA, 2010, BIOL BLOOD MARROW TR, V16, P157, DOI 10.1016/j.bbmt.2009.08.024.
   Gunther S, 2019, AM J PATHOL, V189, P1159, DOI 10.1016/j.ajpath.2019.02.007.
   Mohty M, 2016, BONE MARROW TRANSPL, V51, P906, DOI 10.1038/bmt.2016.130.
   Montani D, 2017, LANCET RESP MED, V5, P125, DOI 10.1016/S2213-2600(16)30438-6.
   Montani D, 2016, EUR RESPIR J, V47, P1518, DOI 10.1183/13993003.00026-2016.
   Perros F, 2015, CIRCULATION, V132, P834, DOI 10.1161/CIRCULATIONAHA.115.014207.
   Ranchoux B, 2015, AM J PATHOL, V185, P356, DOI 10.1016/j.ajpath.2014.10.021.
   Richardson PG, 2018, EXPERT REV CLIN PHAR, V11, P113, DOI 10.1080/17512433.2018.1421943.
   Simonneau G, 2018, EUR RESP J.
   Turco C, 2015, CLIN MED INSIGHTS-ON, V9, P75, DOI {[}10.4137/CMO.S26537, 10.4137/CMO.S26537.].
   Willems E, 2009, EUR RESPIR J, V33, P213, DOI 10.1183/09031936.00157707.}},
Number-of-Cited-References = {{12}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Chest}},
Doc-Delivery-Number = {{KZ9ZB}},
Unique-ID = {{ISI:000523616200003}},
OA = {{Bronze}},
DA = {{2020-05-19}},
}

@article{ ISI:000522841200002,
Author = {Turbil, Emanuele and Guerin, Claude and Schwebel, Carole and Terzi,
   Nicolas},
Title = {{Reverse Triggering: Sometimes It Is Not Only the Diaphragm}},
Journal = {{AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}},
Year = {{2020}},
Volume = {{201}},
Number = {{7, SI}},
Pages = {{E24-E25}},
Month = {{APR 1}},
Publisher = {{AMER THORACIC SOC}},
Address = {{25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA}},
Type = {{Editorial Material}},
Language = {{English}},
Affiliation = {{Turbil, E (Reprint Author), Univ Sassari, Anesthesiol \& Intens Care, Sassari, Italy.
   Turbil, E (Reprint Author), Univ Hosp, Med Intens Care Unit, Grenoble, France.
   Turbil, Emanuele, Univ Sassari, Anesthesiol \& Intens Care, Sassari, Italy.
   Turbil, Emanuele; Guerin, Claude; Terzi, Nicolas, Univ Hosp, Med Intens Care Unit, Grenoble, France.
   Guerin, Claude, Serv Med Intens Reanimat, Lyon, France.
   Guerin, Claude, Univ Lyon, Lyon, France.
   Guerin, Claude, INSERM 955, Creteil, France.
   Terzi, Nicolas, Univ Grenoble Alpes, INSERM, U1042, HP2, Grenoble, France.}},
DOI = {{10.1164/rccm.201907-1358IM}},
ISSN = {{1073-449X}},
EISSN = {{1535-4970}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Cited-References = {{Akoumianaki E, 2013, CHEST, V143, P927, DOI 10.1378/chest.12-1817.}},
Number-of-Cited-References = {{1}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Am. J. Respir. Crit. Care Med.}},
Doc-Delivery-Number = {{KY8QN}},
Unique-ID = {{ISI:000522841200002}},
DA = {{2020-05-19}},
}

@article{ ISI:000522855800014,
Author = {Lantuejoul, Sylvie and Sound-Tsao, Ming and Cooper, Wendy A. and Girard,
   Nicolas and Hirsch, Fred R. and Roden, Anja C. and Lopez-Rios, Fernando
   and Jain, Deepali and Chou, Teh-Ying and Motoi, Noriko and Kerr, Keith
   M. and Yatabe, Yasushi and Brambilla, Elisabeth and Longshore, John and
   Papotti, Mauro and Sholl, Lynette M. and Thunnissen, Erik and Rekhtman,
   Natasha and Borczuk, Alain and Bubendorf, Lukas and Minami, Yuko and
   Beasley, Mary Beth and Botling, Johan and Chen, Gang and Chung,
   Jin-Haeng and Dacic, Sanja and Hwang, David and Lin, Dongmei and
   Moreira, Andre and Nicholson, Andrew G. and Noguchi, Masayuki and
   Pelosi, Giuseppe and Poleri, Claudia and Travis, William and Yoshida,
   Akihiko and Daigneault, Jillian B. and Wistuba, Ignacio I. and
   Mino-Kenudson, Mari},
Title = {{PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC
   Pathology Committee}},
Journal = {{JOURNAL OF THORACIC ONCOLOGY}},
Year = {{2020}},
Volume = {{15}},
Number = {{4}},
Pages = {{499-519}},
Month = {{APR}},
Abstract = {{The recent development of immune checkpoint inhibitors (ICIs) has led to
   promising advances in the treatment of patients with NSCLC and SCLC with
   advanced or metastatic disease. Most ICIs target programmed cell death
   protein 1 (PD-1) or programmed death ligand 1 (PD-L1) axis with the aim
   of restoring antitumor immunity. Multiple clinical trials for ICIs have
   evaluated a predictive value of PD-L1 protein expression in tumor cells
   and tumor-infiltrating immune cells (ICs) by immunohistochemistry (IHC),
   for which different assays with specific IHC platforms were applied. Of
   those, some PD-L1 IHC assays have been validated for the prescription of
   the corresponding agent for first- or second-line treatment. However,
   not all laboratories are equipped with the dedicated platforms, and many
   laboratories have set up in-house or laboratory-developed tests that are
   more affordable than the generally expensive clinical trial-validated
   assays. Although PD-L1 IHC test is now deployed in most pathology
   laboratories, its appropriate implementation and interpretation are
   critical as a predictive biomarker and can be challenging owing to the
   multiple antibody clones and platforms or assays available and given the
   typically small size of samples provided. Because many articles have
   been published since the issue of the IASLC Atlas of PD-L1
   Immunohistochemistry Testing in Lung Cancer, this review by the IASLC
   Pathology Committee provides updates on the indications of ICIs for lung
   cancer in 2019 and discusses important considerations on preanalytical,
   analytical, and postanalytical aspects of PD-L1 IHC testing, including
   specimen type, validation of assays, external quality assurance, and
   training. (C) 2019 International Association for the Study of Lung
   Cancer. Published by Elsevier Inc. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Mino-Kenudson, M (Reprint Author), Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St,Warren 122, Boston, MA 02114 USA.
   Lantuejoul, Sylvie, Ctr Leon Berard Unicanc, Lyon, France.
   Lantuejoul, Sylvie; Brambilla, Elisabeth, Univ Grenoble Alpes, Grenoble, France.
   Sound-Tsao, Ming, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.
   Cooper, Wendy A., Royal Prince Alfred Hosp, Camperdown, NSW, Australia.
   Girard, Nicolas, Inst Curie, Paris, France.
   Girard, Nicolas, Univ Claude Bernard, Lyon, France.
   Hirsch, Fred R., Tisch Canc Inst, Ctr Thorac Oncol, New York, NY USA.
   Hirsch, Fred R.; Beasley, Mary Beth, Mt Sinai Hlth Syst, Ichan Sch Med, New York, NY USA.
   Roden, Anja C., Mayo Clin, Rochester, MN USA.
   Lopez-Rios, Fernando, HM Hosp, Pathol Lab Dianas Terapeut, Madrid, Spain.
   Jain, Deepali, All India Inst Med Sci, New Delhi, India.
   Chou, Teh-Ying, Taipei Vet Gen Hosp, Taipei, Taiwan.
   Motoi, Noriko; Yoshida, Akihiko, Natl Canc Ctr, Tokyo, Japan.
   Kerr, Keith M., Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland.
   Longshore, John, Carolinas Pathol Grp, Charlotte, NC USA.
   Papotti, Mauro, Univ Turin, Turin, Italy.
   Sholl, Lynette M., Brigham \& Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.
   Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.
   Thunnissen, Erik, Vrije Univ Amsterdam, Dept Pathol, Med Ctr, Amsterdam, Netherlands.
   Rekhtman, Natasha; Travis, William, Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
   Borczuk, Alain, Weill Cornell Med, New York, NY USA.
   Bubendorf, Lukas, Univ Basel, Inst Pathol, Basel, Switzerland.
   Minami, Yuko, Ibarakihigashi Natl Hosp, Tokai, Ibaraki, Japan.
   Botling, Johan, Uppsala Univ Hosp, Uppsala, Sweden.
   Chen, Gang, Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China.
   Chung, Jin-Haeng, Seoul Natl Univ, Bundang Hosp, Seoul, South Korea.
   Dacic, Sanja, Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA.
   Hwang, David, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada.
   Lin, Dongmei, Peking Univ, Canc Hosp \& Inst, Dept Pathol, Beijing, Peoples R China.
   Moreira, Andre, NYU, Sch Med, New York, NY USA.
   Nicholson, Andrew G., Royal Brompton \& Harefield NHS Fdn Trust, London, England.
   Nicholson, Andrew G., Imperial Coll, Natl Heart \& Lung Inst, London, England.
   Noguchi, Masayuki, Univ Tsukuba, Tsukuba, Ibaraki, Japan.
   Pelosi, Giuseppe, Univ Milan, Milan, Italy.
   Pelosi, Giuseppe, IRCCS MultiMed, Milan, Italy.
   Poleri, Claudia, Off Pathol Consultants, Buenos Aires, DF, Argentina.
   Daigneault, Jillian B., Int Assoc Study Lung Canc, Aurora, CO USA.
   Wistuba, Ignacio I., Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
   Mino-Kenudson, Mari, Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St,Warren 122, Boston, MA 02114 USA.}},
DOI = {{10.1016/j.jtho.2019.12.107}},
ISSN = {{1556-0864}},
EISSN = {{1556-1380}},
Keywords = {{PD-L1; Immunohistochemistry; NSCLC; SCLC; Immunotherapy}},
Keywords-Plus = {{LIGAND 1 EXPRESSION; IMMUNOHISTOCHEMICAL ASSAYS; ANALYTIC VALIDATION;
   SQUAMOUS-CELL; 22C3 PHARMDX; IHC ASSAY; STAGE IV; ATEZOLIZUMAB;
   NIVOLUMAB; DOCETAXEL}},
Research-Areas = {{Oncology; Respiratory System}},
Web-of-Science-Categories  = {{Oncology; Respiratory System}},
Author-Email = {{mminokenudson@partners.org}},
ORCID-Numbers = {{Tsao, Ming/0000-0002-9160-5405}},
Cited-References = {{Adam J, 2019, J THORAC ONCOL, V14, pS775, DOI 10.1016/j.jtho.2019.08.1666.
   Adam J, 2018, ANN ONCOL, V29, P953, DOI 10.1093/annonc/mdy014.
   Agilent/Dako, PD L1 IHC 22C3 PHARM.
   Agilent/Dako, PD L1 IHC 28 8 PHARM.
   Antonia SJ, 2018, NEW ENGL J MED, V379, P2342, DOI 10.1056/NEJMoa1809697.
   Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937.
   Barlesi F, 2018, ANN ONCOL, V29, P743.
   Bass BP, 2014, ARCH PATHOL LAB MED, V138, P1520, DOI 10.5858/arpa.2013-0691-RA.
   Boothman AM, 2019, J THORAC ONCOL, V14, P1390, DOI 10.1016/j.jtho.2019.04.025.
   Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643.
   Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627.
   Brunnstrom H, 2017, MODERN PATHOL, V30, P1411, DOI 10.1038/modpathol.2017.59.
   Calles A, 2015, J THORAC ONCOL, V10, P1726, DOI 10.1097/JTO.0000000000000687.
   Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713.
   Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493.
   Chung HC, 2019, CANC RES S, V79.
   Cizkova K, 2020, APPL IMMUNOHISTO M M, V28, P166, DOI 10.1097/PAI.0000000000000689.
   Compton CC, 2019, ARCH PATHOL LAB MED, V143, P1346, DOI 10.5858/arpa.2019-0009-SA.
   Conde E, 2018, HISTOPATHOLOGY, V72, P270, DOI 10.1111/his.13346.
   Cooper WA, 2017, CLIN CANCER RES, V23, P4569, DOI 10.1158/1078-0432.CCR-17-0151.
   Cree IA, 2016, HISTOPATHOLOGY, V69, P177, DOI 10.1111/his.12996.
   Dietel M, 2019, LUNG CANCER, V134, P174, DOI 10.1016/j.lungcan.2019.06.012.
   Elliott K, 2015, J CLIN PATHOL, V68, P766, DOI 10.1136/jclinpath-2015-203178.
   Evans M, 2020, PATHOL ONCOL RES, V26, P79, DOI 10.1007/s12253-018-0469-6.
   Fehrenbacher L, 2018, J THORAC ONCOL, V13, P1156, DOI 10.1016/j.jtho.2018.04.039.
   Fitzgibbons PL, 2017, ARCH PATHOL LAB MED, V141, P1247, DOI 10.5858/arpa.2016-0558-CP.
   Forest F, 2019, VIRCHOWS ARCH, V475, P693, DOI 10.1007/s00428-019-02613-w.
   Fujimoto D, 2018, ANTICANCER RES, V38, P6891, DOI 10.21873/anticanres.13065.
   Fujimoto D, 2018, J THORAC ONCOL, V13, P377, DOI 10.1016/j.jtho.2017.11.123.
   Gagne A, 2019, J THORAC ONCOL, V14, P2062, DOI 10.1016/j.jtho.2019.08.2503.
   Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005.
   Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824.
   Gaule P, 2017, JAMA ONCOL, V3, P256, DOI 10.1001/jamaoncol.2016.3015.
   Giunchi F, 2018, APPL IMMUNOHISTO M M, V26, P489, DOI 10.1097/PAI.0000000000000458.
   Goldsmith JD, 2015, ADV ANAT PATHOL, V22, P384, DOI 10.1097/PAP.0000000000000094.
   Hardy LB, 2013, ARCH PATHOL LAB MED, V137, P19, DOI 10.5858/arpa.2011-0676-CP.
   Hellmann MD, 2019, NEW ENGL J MED, V381, P2020, DOI 10.1056/NEJMoa1910231.
   Hendry S, 2018, J THORAC ONCOL, V13, P367, DOI 10.1016/j.jtho.2017.11.112.
   Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7.
   Heymann JJ, 2017, CANCER CYTOPATHOL, V125, P896, DOI 10.1002/cncy.21937.
   Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228.
   Horn L, 2018, NEW ENGL J MED, V379, P2220, DOI 10.1056/NEJMoa1809064.
   Horn L, 2018, EUR J CANCER, V101, P201, DOI 10.1016/j.ejca.2018.06.031.
   Ilie M, 2016, ANN ONCOL, V27, P147, DOI 10.1093/annonc/mdv489.
   Ilie M, 2018, CANCER CYTOPATHOL, V126, P264, DOI 10.1002/cncy.21977.
   Jain D, 2018, CYTOPATHOLOGY, V29, P550, DOI 10.1111/cyt.12605.
   Jotte R, 2019, J THORAC ONCOL, V14, pS243, DOI 10.1016/j.jtho.2019.08.484.
   Kerr K, 2018, J THORAC ONCOL, V13, pS325, DOI 10.1016/j.jtho.2018.08.247.
   Kerr KM, 2019, LUNG CANCER, V131, P95, DOI 10.1016/j.lungcan.2019.03.012.
   Kim H, 2017, ONCOTARGET, V8, P98524, DOI 10.18632/oncotarget.21567.
   Kim I, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014972.
   Kim J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30277-0.
   Li HJ, 2019, TRANSL LUNG CANCER R, V8, P429, DOI 10.21037/tlcr.2019.08.04.
   Liu YW, 2018, CLIN LUNG CANCER, V19, pE421, DOI 10.1016/j.cllc.2018.02.008.
   Lloyd IE, 2019, APPL IMMUNOHISTO M M, V27, P107, DOI 10.1097/PAI.0000000000000572.
   Lozano MD, 2019, CANCER CYTOPATHOL, V127, P470, DOI 10.1002/cncy.22155.
   Mansfield AS, 2016, ANN ONCOL, V27, P1953, DOI 10.1093/annonc/mdw289.
   Marchetti A, 2017, J THORAC ONCOL, V12, P1654, DOI 10.1016/j.jtho.2017.07.031.
   Maxwell P, 2016, CANCER CYTOPATHOL, V124, P540, DOI 10.1002/cncy.21692.
   McLaughlin J, 2016, JAMA ONCOL, V2, P46, DOI 10.1001/jamaoncol.2015.3638.
   Midha A, 2016, ASCO M, V34, P3025.
   Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7.
   Munari E, 2019, CANCER CYTOPATHOL, V127, P52, DOI 10.1002/cncy.22083.
   Munari Enrico, 2018, Oncotarget, V9, P30465, DOI 10.18632/oncotarget.25770.
   Munari E, 2018, AM J SURG PATHOL, V42, P1384, DOI 10.1097/PAS.0000000000001105.
   Munari E, 2018, J THORAC ONCOL, V13, P1113, DOI 10.1016/j.jtho.2018.04.017.
   Naito T, 2019, J THORAC ONCOL, V14, P1818, DOI 10.1016/j.jtho.2019.06.019.
   Neuman T, 2016, J THORAC ONCOL, V11, P1863, DOI 10.1016/j.jtho.2016.08.146.
   Noll B, 2018, CANCER CYTOPATHOL, V126, P342, DOI 10.1002/cncy.21987.
   NordiQC, PD L1.
   O'Malley DP, 2019, MODERN PATHOL, V32, P929, DOI 10.1038/s41379-019-0210-3.
   Omori S, 2018, INT J CLIN ONCOL, V23, P1052, DOI 10.1007/s10147-018-1305-4.
   Paz-Ares L, 2019, J THORAC ONCOL, V14, pS7, DOI 10.1016/j.jtho.2019.08.061.
   Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865.
   Phillips T, 2015, APPL IMMUNOHISTO M M, V23, P541, DOI 10.1097/PAI.0000000000000256.
   Ratcliffe MJ, 2017, CLIN CANCER RES, V23, P3585, DOI 10.1158/1078-0432.CCR-16-2375.
   Rebelatto MC, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0545-8.
   Reck M, 2019, J CLIN ONCOL, V37, P537, DOI 10.1200/JCO.18.00149.
   Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774.
   Rehman JA, 2017, MODERN PATHOL, V30, P340, DOI 10.1038/modpathol.2016.186.
   Rimm DL, 2017, JAMA ONCOL, V3, P1051, DOI 10.1001/jamaoncol.2017.0013.
   Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X.
   Rizvi NA, 2018, ANN ONCOL, V29.
   Roche Tissue Diagnostics, VENTANA PD L1 SP263.
   Roche Tissue Diagnostics, VENTANA PD L1 SP142.
   Roge R, 2017, APPL IMMUNOHISTO M M, V25, P381, DOI 10.1097/PAI.0000000000000534.
   Russell-Goldman E, 2018, CANCER CYTOPATHOL, V126, P253, DOI 10.1002/cncy.21973.
   Scheel AH, 2016, MODERN PATHOL, V29, P1165, DOI 10.1038/modpathol.2016.117.
   Sheng J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20090.
   Skov BG, 2017, APPL IMMUNOHISTO M M, V25, P453, DOI 10.1097/PAI.0000000000000540.
   Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948.
   Spigel D., 2019, ANN ONCOL, V30, pv851, DOI {[}10.1093/annonc/mdz394, DOI 10.1093/ANNONC/MDZ394].
   Strickland AL, 2020, AM J CLIN PATHOL, V153, P258, DOI {[}10.1093/AJCP/AQZ161, 10.1093/ajcp/aqz161].
   Stuart LN, 2017, ARCH PATHOL LAB MED, V141, P1255, DOI 10.5858/arpa.2016-0559-CP.
   Thunnissen E, 2019, ARCH PATHOL LAB MED, V143, P11, DOI 10.5858/arpa.2018-0410-ED.
   Thunnissen E, 2018, ARCH PATHOL LAB MED, V142, P408, DOI 10.5858/arpa.2017-0106-SA.
   Torlakovic EE, 2019, ARCH PATHOL LAB MED, V143, P907, DOI 10.5858/arpa.2019-0056-LE.
   Torous Vanda F, 2018, J Am Soc Cytopathol, V7, P133, DOI 10.1016/j.jasc.2018.02.003.
   Tsao MS, 2018, J THORAC ONCOL, V13, P1302, DOI 10.1016/j.jtho.2018.05.013.
   Tsao MS, 2017, IASLC ATLAS PD L1 IM.
   U.S. Food and Drug Administration, PD L1 IHC 22C3 PHARM.
   Uruga H, 2017, J THORAC ONCOL, V12, P458, DOI 10.1016/j.jtho.2016.10.015.
   US NEQAS, UK NEQAS ICC ISH MOD.
   van Seijen M, 2019, VIRCHOWS ARCH, V475, P191, DOI 10.1007/s00428-019-02595-9.
   Vokes EE, 2018, ANN ONCOL, V29, P959, DOI 10.1093/annonc/mdy041.
   Wang H, 2018, ANN ONCOL, V29, P1417, DOI 10.1093/annonc/mdy126.
   West H, 2019, LANCET ONCOL, V20, P924, DOI 10.1016/S1470-2045(19)30167-6.
   Zhang PP, 2016, CANCER SCI, V107, P1563, DOI 10.1111/cas.13072.}},
Number-of-Cited-References = {{108}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{J. Thorac. Oncol.}},
Doc-Delivery-Number = {{KY8WC}},
Unique-ID = {{ISI:000522855800014}},
DA = {{2020-05-19}},
}

@article{ ISI:000522855800015,
Author = {Poirier, John T. and George, Julie and Owonikoko, Taofeek K. and Berns,
   Anton and Brambilla, Elisabeth and Byers, Lauren A. and Carbone, David
   and Chen, Huanhuan J. and Christensen, Camilla L. and Dive, Caroline and
   Farago, Anna and Govindan, Ramaswamy and Hann, Christine and Hellmann,
   Matthew D. and Horn, Leora and Johnson, Jane E. and Ju, Young S. and
   Kang, Sumin and Krasnow, Mark and Lee, James and Lee, Se-Hoon and
   Lehman, Jonathan and Lok, Benjamin and Lovly, Christine and MacPherson,
   David and McFadden, David and Minna, John and Oser, Matthew and Park,
   Keunchil and Park, Kwon-Sik and Pommier, Yves and Quaranta, Vito and
   Ready, Neal and Sage, Julien and Scagliotti, Giorgio and Sos, Martin L.
   and Sutherland, Kate D. and Travis, William D. and Vakoc, Christopher R.
   and Wait, Sarah J. and Wistuba, Ignacio and Wong, Kwok Kin and Zhang,
   Hua and Daigneault, Jillian and Wiens, Jacinta and Rudin, Charles M. and
   Oliver, Trudy G.},
Title = {{New Approaches to SCLC Therapy: From the Laboratory to the Clinic}},
Journal = {{JOURNAL OF THORACIC ONCOLOGY}},
Year = {{2020}},
Volume = {{15}},
Number = {{4}},
Pages = {{520-540}},
Month = {{APR}},
Abstract = {{The outcomes of patients with SCLC have not yet been substantially
   impacted by the revolution in precision oncology, primarily owing to a
   paucity of genetic alterations in actionable driver oncogenes.
   Nevertheless, systemic therapies that include immunotherapy are
   beginning to show promise in the clinic. Although, these results are
   encouraging, many patients do not respond to, or rapidly recur after,
   current regimens, necessitating alternative or complementary therapeutic
   strategies. In this review, we discuss ongoing investigations into the
   pathobiology of this recalcitrant cancer and the therapeutic
   vulnerabilities that are exposed by the disease state. Included within
   this discussion, is a snapshot of the current biomarker and clinical
   trial landscapes for SCLC. Finally, we identify key knowledge gaps that
   should be addressed to advance the field in pursuit of reduced SCLC
   mortality. This review largely summarizes work presented at the Third
   Biennial International Association for the Study of Lung Cancer SCLC
   Meeting. (C) 2020 International Association for the Study of Lung
   Cancer. Published by Elsevier Inc. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Oliver, TG (Reprint Author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.
   Poirier, John T.; Wong, Kwok Kin; Zhang, Hua, NYU, Langone Hlth, Perlmutter Canc Ctr, New York, NY USA.
   George, Julie; Sos, Martin L., Univ Cologne, Ctr Integrated Oncol Cologne Bonn, Dept Translat Genom, Fac Med, Cologne, Germany.
   Owonikoko, Taofeek K.; Kang, Sumin, Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.
   Berns, Anton, Netherlands Canc Inst, Amsterdam, Netherlands.
   Brambilla, Elisabeth; Wiens, Jacinta, Univ Grenoble Alpes, Grenoble, France.
   Byers, Lauren A.; Wistuba, Ignacio, MD Anderson Canc Ctr, Houston, TX USA.
   Carbone, David; Lee, James, Ohio State Univ, Columbus, OH 43210 USA.
   Chen, Huanhuan J., Weill Cornell Med Coll, New York, NY USA.
   Christensen, Camilla L.; Oser, Matthew, Dana Farber Canc Inst, Boston, MA 02115 USA.
   Dive, Caroline, Manchester Inst, Canc Res United Kingdom, Manchester, Lancs, England.
   Farago, Anna, Massachusetts Gen Hosp, Boston, MA 02114 USA.
   Govindan, Ramaswamy, Washington Univ, St Louis, MO 63110 USA.
   Hann, Christine, Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   Hellmann, Matthew D.; Travis, William D.; Rudin, Charles M., Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
   Horn, Leora; Lehman, Jonathan; Lovly, Christine; Quaranta, Vito, Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.
   Johnson, Jane E.; McFadden, David; Minna, John, UT Southwestern Med Ctr, Dallas, TX USA.
   Ju, Young S., Korea Adv Inst Sci \& Technol, Daejeon, South Korea.
   Krasnow, Mark; Sage, Julien, Stanford Univ, Sch Med, Stanford, CA 94305 USA.
   Lee, Se-Hoon; Park, Keunchil, Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea.
   Lok, Benjamin, Princess Margaret Canc Ctr, Toronto, ON, Canada.
   MacPherson, David, Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   Park, Kwon-Sik, Univ Virginia, Charlottesville, VA USA.
   Pommier, Yves, NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   Ready, Neal, Duke Univ, Durham, NC USA.
   Scagliotti, Giorgio, Univ Torino, Turin, Italy.
   Sos, Martin L., Univ Hosp Cologne, Inst Pathol, Mol Pathol, Cologne, Germany.
   Sos, Martin L., Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.
   Sutherland, Kate D., Walter \& Eliza Hall Inst Med Res, Parkville, Vic, Australia.
   Vakoc, Christopher R., Cold Spring Harbor Lab, New York, NY USA.
   Wait, Sarah J.; Oliver, Trudy G., Huntsman Canc Inst, Salt Lake City, UT USA.
   Wait, Sarah J.; Oliver, Trudy G., Univ Utah, Salt Lake City, UT USA.
   Daigneault, Jillian; Wiens, Jacinta, Int Assoc Study Lung Canc, Aurora, CO USA.}},
DOI = {{10.1016/j.jtho.2020.01.016}},
ISSN = {{1556-0864}},
EISSN = {{1556-1380}},
Keywords = {{SCLC; Gene mutations; Therapy; Neuroendocrine; ASCL1}},
Keywords-Plus = {{CELL LUNG-CANCER; CIRCULATING TUMOR-CELLS; PARP INHIBITOR; IN-VIVO;
   INDEPENDENT PREDICTOR; STEM-CELLS; OPEN-LABEL; HETEROGENEITY;
   COMBINATION; MUTATIONS}},
Research-Areas = {{Oncology; Respiratory System}},
Web-of-Science-Categories  = {{Oncology; Respiratory System}},
Author-Email = {{trudy.oliver@hci.utah.edu}},
ORCID-Numbers = {{Poirier, John/0000-0001-9795-5644}},
Funding-Acknowledgement = {{National Institutes of Health (NIH)United States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USA {[}R01 CA213448,
   U01 CA213359, U01 CA231844, U24 CA213274, U01 CA213338, R21 CA216504,
   R01 CA207295]; NCI Small Cell Research Consortium Coordinating Center
   {[}U24 CA213274]}},
Funding-Text = {{The authors were supported by grants from the National Institutes of
   Health (NIH) R01 CA213448 (Dr. Poirier and Dr. Rudin), U01 CA213359 (Dr.
   Poirier), U01 CA231844 (Dr. Oliver and Dr. Govindan), U24 CA213274 (Dr.
   Rudin and Dr. Oliver), U01 CA213338 (Dr. Minna), R21 CA216504 (Dr.
   Oliver), and R01 CA207295 (Dr. Byers). The NCI Small Cell Research
   Consortium Coordinating Center (U24 CA213274) and the International
   Association for the Study of Lung Cancer supported the meeting on which
   this review is based. The authors also thank Dr. Peter Ujhazy, Dr. Eva
   Szabo, and Dr. Suzanne Forry from the National Cancer Institute (NCI),
   and Dr. Adi Gazdar, whose pioneering work has greatly impacted the
   discoveries described in this study, and to whom the Third Biennial
   International Association for the Study of Lung Cancer (IASLC) SCLC
   meeting and this manuscript was dedicated to.}},
Cited-References = {{Adumeau P, 2018, BIOCONJUGATE CHEM, V29, P1364, DOI 10.1021/acs.bioconjchem.8b00081.
   Almodovar K, 2018, J THORAC ONCOL, V13, P112, DOI 10.1016/j.jtho.2017.09.1951.
   Aly RG, 2019, J THORAC ONCOL, V14, P1583, DOI 10.1016/j.jtho.2019.05.009.
   Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5.
   Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22.
   Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547.
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003.
   Belani CP, 2016, CANCER-AM CANCER SOC, V122, P2371, DOI 10.1002/cncr.30062.
   Belgiovine C, 2017, BRIT J CANCER, V117, P628, DOI 10.1038/bjc.2017.205.
   Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0.
   Borromeo MD, 2016, CELL REP, V16, P1259, DOI 10.1016/j.celrep.2016.06.081.
   Bragelmann J, 2017, CELL CYCLE, V16, P1489, DOI 10.1080/15384101.2017.1339849.
   Bunn PA, 2016, J THORAC ONCOL, V11, P453, DOI 10.1016/j.jtho.2016.01.012.
   Burr ML, 2019, CANCER CELL, V36, P385, DOI 10.1016/j.ccell.2019.08.008.
   Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112.
   Calvo E, 2017, ANN ONCOL, V28, P2559, DOI 10.1093/annonc/mdx357.
   Carbone DP, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15\_suppl.8507.
   Cardnell RJ, 2017, ONCOTARGET, V8, P73419, DOI 10.18632/oncotarget.20621.
   Carter L, 2017, NAT MED, V23, P114, DOI 10.1038/nm.4239.
   Chalishazar MD, 2019, CLIN CANCER RES, V25, P5107, DOI 10.1158/1078-0432.CCR-18-4140.
   Chen HJ, 2019, J EXP MED, V216, P674, DOI 10.1084/jem.20181155.
   Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019.
   Chu QS, 2017, ANN ONCOL, V28, pv539.
   Dammed MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11371-x.
   de Bono J, 2017, CANCER DISCOV, V7, P620, DOI 10.1158/2159-8290.CD-16-1250.
   de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462.
   de Carcer G, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030208.
   Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052.
   Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930.
   Doerr F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15840-5.
   Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711.
   Doroshow DB, 2017, ANN ONCOL, V28, P1776, DOI 10.1093/annonc/mdx157.
   DOYLE A, 1985, J EXP MED, V161, P1135, DOI 10.1084/jem.161.5.1135.
   Drapkin BJ, 2018, CANCER DISCOV, V8, P600, DOI 10.1158/2159-8290.CD-17-0935.
   Dungey FA, 2008, INT J RADIAT ONCOL, V72, P1188, DOI 10.1016/j.ijrobp.2008.07.031.
   Eguchi T, 2019, J THORAC ONCOL, V14, P87, DOI 10.1016/j.jtho.2018.09.005.
   Faber AC, 2014, CANCER DISCOV, V4, P42, DOI 10.1158/2159-8290.CD-13-0315.
   Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360.
   Farago AF, 2019, CANCER DISCOV, V9, P1372, DOI 10.1158/2159-8290.CD-19-0582.
   Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286.
   Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208.
   Gani C, 2015, RADIOTHER ONCOL, V116, P486, DOI 10.1016/j.radonc.2015.08.003.
   Gardner EE, 2017, CANCER CELL, V31, P286, DOI 10.1016/j.ccell.2017.01.006.
   Gardner EE, 2014, CANCER RES, V74, P2846, DOI 10.1158/0008-5472.CAN-13-3460.
   George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664.
   Giffin MJ, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-3632.
   Gong XQ, 2019, CANCER DISCOV, V9, P248, DOI 10.1158/2159-8290.CD-18-0469.
   Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386.
   Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897.
   Halvaei S, 2018, MOL THER-NUCL ACIDS, V10, P131, DOI 10.1016/j.omtn.2017.11.014.
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9.
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013.
   Harlow ML, 2019, CLIN CANCER RES, V25, P3417, DOI 10.1158/1078-0432.CCR-18-3511.
   Helfrich BA, 2016, MOL CANCER THER, V15, P2314, DOI 10.1158/1535-7163.MCT-16-0298.
   Hellmann MD, 2018, CANCER CELL, V33, P853, DOI 10.1016/j.ccell.2018.04.001.
   Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600.
   Horn L, 2018, NEW ENGL J MED, V379, P2220, DOI 10.1056/NEJMoa1809064.
   Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716.
   Hou JM, 2009, AM J PATHOL, V175, P808, DOI 10.2353/ajpath.2009.090078.
   Howlader N, 2019, SEER CANC STAT REV 1.
   Hu JM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01942-1.
   Huang F, 2018, CELL METAB, V28, P369, DOI 10.1016/j.cmet.2018.06.005.
   Huang YH, 2018, GENE DEV, V32, P915, DOI 10.1101/gad.314815.118.
   Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288.
   Jia DS, 2018, CANCER DISCOV, V8, P1422, DOI 10.1158/2159-8290.CD-18-0385.
   Jin LT, 2018, CANCER CELL, V34, P315, DOI 10.1016/j.ccell.2018.06.012.
   Keshet R, 2018, NAT REV CANCER, V18, P634, DOI 10.1038/s41568-018-0054-z.
   Kim K-B, ONCOGENIC ROLE FGFR1.
   Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036.
   Laird JH, 2018, CLIN CANCER RES, V24, P5143, DOI 10.1158/1078-0432.CCR-18-0401.
   Lallo A, 2019, BRIT J PHARMACOL, V176, P436, DOI 10.1111/bph.14542.
   Lallo A, 2018, CLIN CANCER RES, V24, P5153, DOI 10.1158/1078-0432.CCR-17-2805.
   Lam LT, 2017, MOL CANCER THER, V16, P1511, DOI 10.1158/1535-7163.MCT-16-0459.
   Lee JK, 2017, J CLIN ONCOL, V35, P3065, DOI 10.1200/JCO.2016.71.9096.
   Lim JS, 2017, NATURE, V545, P360, DOI 10.1038/nature22323.
   Liu ZX, 2017, TRANSL ONCOL, V10, P22, DOI 10.1016/j.tranon.2016.10.003.
   Lok BH, 2017, CLIN CANCER RES, V23, P523, DOI 10.1158/1078-0432.CCR-16-1040.
   Lu SH, 2017, J THORAC ONCOL, V12, P223, DOI 10.1016/j.jtho.2016.09.129.
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784.
   McColl K, 2017, ONCOTARGET, V8, P73745, DOI 10.18632/oncotarget.20572.
   McMillan EA, 2018, CELL, V173, P864, DOI 10.1016/j.cell.2018.03.028.
   Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581.
   Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4.
   Mollaoglu G, 2017, CANCER CELL, V31, P270, DOI 10.1016/j.ccell.2016.12.005.
   Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7.
   Morinaga R, 2007, LUNG CANCER, V58, P411, DOI 10.1016/j.lungcan.2007.05.014.
   Murai J, 2016, ONCOTARGET, V7, P76534, DOI 10.18632/oncotarget.12266.
   Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753.
   Neptune ER, 2008, J BIOL CHEM, V283, P21160, DOI 10.1074/jbc.M708692200.
   Nicholson SA, 2002, AM J SURG PATHOL, V26, P1184, DOI 10.1097/00000478-200209000-00009.
   Niederst MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7377.
   Olson CM, 2019, CELL CHEM BIOL, V26, P792, DOI 10.1016/j.chembiol.2019.02.012.
   Osborne JK, 2014, MOL BIOL CELL, V25, P1782, DOI 10.1091/mbc.E13-06-0316.
   Osborne JK, 2013, P NATL ACAD SCI USA, V110, P6524, DOI 10.1073/pnas.1303932110.
   Oser MG, 2019, CANCER DISCOV, V9, P230, DOI 10.1158/2159-8290.CD-18-0389.
   Ott PA, 2017, J CLIN ONCOL, V35, P3823, DOI 10.1200/JCO.2017.72.5069.
   Ouadah Y, 2019, CELL, V179, P403, DOI 10.1016/j.cell.2019.09.010.
   Owonikoko TK, 2019, J CLIN ONCOL, V37, P222, DOI 10.1200/JCO.18.00264.
   Palma JP, 2009, CLIN CANCER RES, V15, P7277, DOI 10.1158/1078-0432.CCR-09-1245.
   Park KS, 2011, CELL CYCLE, V10, P2806, DOI 10.4161/cc.10.16.17012.
   PAZARES LG, 2019, J CLIN ONCOL S, V37.
   Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396.
   Pietanza MC, 2018, J CLIN ONCOL, V36, P2386, DOI 10.1200/JCO.2018.77.7672.
   Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6.
   Poirier JT, 2015, ONCOGENE, V34, P5869, DOI 10.1038/onc.2015.38.
   Polley E, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw122.
   Ponath P, 2018, CLIN CANCER RES, V24, P5178, DOI 10.1158/1078-0432.CCR-18-0018.
   Potter DS, 2016, MOL CANCER THER, V15, P1248, DOI 10.1158/1535-7163.MCT-15-0885.
   Pusztai L, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15\_suppl.586.
   Rajapakse VN, 2018, ISCIENCE, V10, P247, DOI 10.1016/j.isci.2018.11.029.
   Reck M, 2018, ANN ONCOL, V29, P43.
   Rekhtman N, 2019, MODERN PATHOL, V32, P1106, DOI 10.1038/s41379-019-0248-2.
   Rudin CM, 2019, NAT REV CANCER, V19, P289, DOI 10.1038/s41568-019-0133-9.
   Rudin CM, 2017, LANCET ONCOL, V18, P42, DOI {[}10.1016/S1470-2045(16)30565-4, 10.1016/s1470-2045(16)30565-4].
   Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405.
   Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090.
   Nunez GS, 2016, MOL CANCER THER, V15, P2399, DOI 10.1158/1535-7163.MCT-16-0172.
   Saunders LR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9459.
   Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228.
   Schultheis AM, 2014, MODERN PATHOL, V27, P214, DOI 10.1038/modpathol.2013.141.
   Semenova EA, 2016, CELL REP, V16, P631, DOI 10.1016/j.celrep.2016.06.020.
   Sen T, 2019, J THORAC ONCOL, V14, P2152, DOI 10.1016/j.jtho.2019.08.009.
   Sen T, 2019, CANCER DISCOV, V9, P646, DOI 10.1158/2159-8290.CD-18-1020.
   Sen T, 2017, CANCER RES, V77, P3870, DOI 10.1158/0008-5472.CAN-16-3409.
   Senra JM, 2011, MOL CANCER THER, V10, P1949, DOI 10.1158/1535-7163.MCT-11-0278.
   Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003.
   Sharma SK, 2017, CANCER RES, V77, P3931, DOI 10.1158/0008-5472.CAN-17-0299.
   Shen JF, 2019, CANCER RES, V79, P311, DOI 10.1158/0008-5472.CAN-18-1003.
   Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622.
   Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109.
   Stathis A, 2018, CANCER DISCOV, V8, P24, DOI 10.1158/2159-8290.CD-17-0605.
   Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019.
   Swanton C, 2016, NEW ENGL J MED, V374, P1864, DOI 10.1056/NEJMra1504688.
   Teicher BA, 2017, CANCER MED-US, V6, P1952, DOI 10.1002/cam4.1131.
   Thomas A, 2019, J THORAC ONCOL, V14, P1447, DOI 10.1016/j.jtho.2019.04.026.
   Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630.
   Verhagen CVM, 2015, RADIOTHER ONCOL, V116, P358, DOI 10.1016/j.radonc.2015.03.028.
   Cespedes MV, 2016, DIS MODEL MECH, V9, P1461, DOI 10.1242/dmm.026369.
   Wagner AH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06162-9.
   Wang HG, 2017, ONCOTARGET, V8, P86312, DOI 10.18632/oncotarget.21146.
   Weiskopf K, 2016, J CLIN INVEST, V126, P2610, DOI 10.1172/JCI81603.
   Wooten DJ, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007343.
   Wu N, 2016, ONCOTARGET, V7, P57514, DOI 10.18632/oncotarget.11583.
   Yang D, 2019, ELIFE, V8, DOI 10.7554/eLife.50616.
   Yang D, 2018, CANCER DISCOV, V8, P1316, DOI 10.1158/2159-8290.CD-17-0987.
   Yu Hongxia, 2017, Asian Journal of Ecotoxicology, V12, P1.
   Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610.
   Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930.
   Zhang W, 2018, TRANSL LUNG CANCER R, V7, P32, DOI 10.21037/tlcr.2018.02.02.}},
Number-of-Cited-References = {{149}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{J. Thorac. Oncol.}},
Doc-Delivery-Number = {{KY8WC}},
Unique-ID = {{ISI:000522855800015}},
OA = {{Bronze}},
DA = {{2020-05-19}},
}
